Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MENASCORP Plus
- Development stage
- Unknown
- Lead developer
- VINS Bio Products
- Modality
- Antibody-Based Therapeutics
- Administration
- Intravenous, Intramuscular
01
Overview
MENASCORP Plus is a polyvalent anti-scorpion venom serum developed and manufactured by VinsBioproducts. It is an equine-derived biologic composed of polyclonal antibodies (immunoglobulins) purified from the plasma of healthy horses hyperimmunized against the venoms of three medically significant scorpion species: *Leiurus quinquestriatus*, *Androctonus amoreuxi*, and *Androctonus australis hector*. The manufacturing process involves pepsin digestion, which typically yields F(ab')2 antibody fragments, followed by controlled heating and caprylic acid precipitation to ensure purity and safety. MENASCORP Plus is indicated for the treatment of scorpion envenomation, where the antibodies bind to and neutralize circulating toxins, preventing their interaction with physiological targets and mitigating the clinical effects of the sting.
- Brand names
- MENASCORP Plus
- Other names
- polyvalent anti-scorpion venom serumscorpion antivenom (equine, polyvalent)
02
Targets
Androctonus amoreuxi venom neurotoxins
Beyond the preview
Go deeper on MENASCORP Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MENASCORP Plus.